Kim L Kanki

Title: Kim L Kanki: Innovator in Gene Targeting Technologies

Introduction

Kim L Kanki is a notable inventor based in Boxford, MA (US). She has made significant contributions to the field of genetics, particularly in gene targeting and gene trapping methodologies. Her innovative work has implications for various applications in genetic research and biotechnology.

Latest Patents

Kim L Kanki holds a patent for a "Conditional knockout method for gene trapping and gene targeting using an inducible gene silencer." This method allows for the conditional alteration of gene function and genetic sequences, which can be utilized in gene trapping and gene targeting. The patent details a genetic sequence that includes an inducible gene silencer, a splice acceptor sequence, an internal ribosomal entry site (IRES) sequence, a nucleotide sequence coding for a reporter protein, a polyadenylation sequence, and a pair of oppositely oriented recombination site sequences. These elements work together to facilitate single cycle inversions in the presence of a suitable recombinase enzyme.

Career Highlights

Kim L Kanki is associated with Wyeth, a prominent company in the pharmaceutical and biotechnology sectors. Her work at Wyeth has allowed her to focus on advancing genetic research and developing innovative solutions in gene manipulation.

Collaborations

Kim collaborates with G Roger Askew, who is also involved in genetic research. Their partnership enhances the potential for groundbreaking discoveries in the field.

Conclusion

Kim L Kanki's contributions to gene targeting technologies exemplify the impact of innovative thinking in genetics. Her patent and work at Wyeth highlight her role as a key figure in advancing genetic research.